| View |
|
DRP-8044-04
|
Tobramycin
|
Tobralyf
|
3 mg/mL (0.3 % w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Antibacterial (Aminoglycoside)
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
CLIDP Conversion
|
25 March 2024
|
05 December 2028
|
| View |
|
DRP-8396-06
|
Omeprazole (as Sodium)
|
Omacare
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump Inhibitor
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
10 March 2024
|
19 November 2028
|
| View |
|
DRP-8534-01
|
Olanzapine
|
Lanspro-20
|
20 mg
|
Orally Disintegrating Tablet
|
Antipsychotic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 March 2024
|
31 October 2029
|
| View |
|
DRP-8535-03
|
Olanzapine
|
Lupilan
|
10 mg
|
Orally Disintegrating Tablet
|
Antipsychotic
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
29 March 2024
|
31 October 2029
|
| View |
|
DRP-8536-02
|
Olanzapine
|
Lupilan
|
5 mg
|
Orally Disintegrating Tablet
|
Antipsychotic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 March 2024
|
31 October 2029
|
| View |
|
DRP-8580-04
|
Docetaxel
|
Docegard 80
|
40 mg / mL (80 mg / 2 mL)
|
Concentrate Solution for IV Infusion
|
Antineoplastic
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
28 March 2024
|
18 December 2024
|
| View |
|
DRP-8583-03
|
Paclitaxel
|
Paclimed-100
|
6 mg/mL (100 mg/16.7 mL)
|
Concentrate Solution for Infusion (IV)
|
Antineoplastic
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
25 March 2024
|
18 December 2024
|
| View |
|
DRP-8586-13
|
Trimetazidine dihydrochloride
|
Trigil
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 March 2024
|
18 December 2029
|
| View |
|
DRP-8640-07
|
Azithromycin (as dihydrate)
|
Retamaxz
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
21 March 2024
|
22 January 2025
|
| View |
|
DRP-8798-01
|
Ascorbic Acid + Zinc
|
None
|
500 mg (eq. to 605.19 mg Calcium Ascorbate)/ 20 mg (eq. to 55 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamins/Minerals
|
Lifesquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
26 March 2024
|
30 March 2025
|
| View |
|
DRP-8799-01
|
Ascorbic Acid
|
None
|
500 mg (equivalent to 605.19 mg Calcium Ascorbate)
|
Capsule
|
Vitamins
|
Lifesquare Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
26 March 2024
|
30 March 2025
|
| View |
|
DRP-8838-03
|
Levocetirizine hydrochloride
|
Zyvosal
|
2.5 mg / 5 mL
|
Syrup
|
Antihistamine
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
27 October 2024
|
02 July 2030
|
| View |
|
DRP-8933-01
|
Buclizine HCl + Multivitamin + Iron
|
Appetech
|
(See reverse for formulation)
|
Capsule
|
Vitamins + Minerals
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
21 March 2024
|
01 July 2025
|
| View |
|
DRP-8985-09
|
Losartan Potassium
|
Pulsara
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
21 March 2024
|
21 July 2025
|
| View |
|
DRP-9124-10
|
Lactulose
|
Lactuden
|
3.33g / 5 mL
|
Oral Solution
|
Laxative
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 March 2024
|
04 September 2025
|
| View |
|
DRP-9244-09
|
Salbutamol (as sulfate)
|
Ronivent
|
1 mg / mL (2.5 mg/2.5 mL)
|
Solution for Inhalation
|
Bronchodilator (Selective beta-2-adrenoreceptor agonist)
|
Legency Remedies Pvt. Ltd
|
India
|
CLIDP Conversion
|
29 March 2024
|
09 June 2025
|
| View |
|
DRP-9354-01
|
Betahistine dihydrochloride
|
Betaquest
|
16 mg
|
Tablet
|
Anti-vertigo
|
Healer's Lab (Unit II)
|
India
|
CLIDP Conversion
|
25 March 2024
|
04 December 2025
|
| View |
|
DRP-9420-01
|
Omeprazole
|
Qmeprazole
|
40 mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Jiangxi Xierkangtai Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
26 March 2024
|
05 December 2028
|
| View |
|
DRP-944
|
Sterile Water For Injection
|
None
|
None
|
None
|
Parenteral
|
Best Drug Industries, Inc
|
Philippines
|
Renewal
|
09 March 2024
|
23 February 2030
|
| View |
|
DRP-9896-05
|
Budesonide
|
Maxsunide
|
250 mcg / mL (500 mcg/ mL)
|
Suspension for Nebulization
|
Corticosteroid
|
AXA Parenterals Ltd.
|
India
|
CLIDP Conversion
|
16 March 2024
|
24 June 2025
|